Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Clinician Scientist - Phase 1

Direct Payment

$187,500.00

Exome Sequencing of Familial Colorectal Cancer

FY 2010-11

Summary
Colorectal cancer (CRC) is common and kills over 60,000 men and women each year in North America. Up to a third of cases can be attributed to the genes you inherited from your mother and father. In five to ten percent of cases the strong predisposition to CRC is thought to be due to mutations in single genes. Thus if, the causative gene is identified in a family, family members can be tested for the gene and if they have it, undergo regular screening or alternatives like prophylactic surgery to remove the organ where cancer is likely to occur. Many families with familial CRC are not found to carry genes known to predispose to cancer. Identification of further cancer genes would greatly benefit these families. Recently, advances in ways of quickly analyzing all of the genes in a family have enabled us to see which genetic variations correlate in a family with susceptibility to CRC. By identifying genes that predispose to cancer, we might also find out more about how to prevent or cure cancer.
Program
CIHR Clinician Scientist - Phase 1
Location
New York, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
213593
Name
Schrader Kasmintan A
Region
New York
Country
United States of America
Orgtype
Research Institution
Instname2
Genetics
Theme2
Clinical
Prcname2
Clinician Scientist
Projecttitle
Exome Sequencing of Familial Colorectal Cancer
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$187,500
Cihrequipment2
$0
Programname2
CIHR Clinician Scientist - Phase 1
Keyworddelim
Cancer Genetics; Exome Capture; Genomic Analysis; Germline; Hereditary Cancer; Next-Generation Sequencing
Abstract
Colorectal cancer (CRC) is common and kills over 60,000 men and women each year in North America. Up to a third of cases can be attributed to the genes you inherited from your mother and father. In five to ten percent of cases the strong predisposition to CRC is thought to be due to mutations in single genes. Thus if, the causative gene is identified in a family, family members can be tested for the gene and if they have it, undergo regular screening or alternatives like prophylactic surgery to remove the organ where cancer is likely to occur. Many families with familial CRC are not found to carry genes known to predispose to cancer. Identification of further cancer genes would greatly benefit these families. Recently, advances in ways of quickly analyzing all of the genes in a family have enabled us to see which genetic variations correlate in a family with susceptibility to CRC. By identifying genes that predispose to cancer, we might also find out more about how to prevent or cure cancer.
Competitiondate
201009
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Schrader, Kasmintan A
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $187,500~ $0~